Upstream anticoagulation for patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28540
Abstract: To assess the relationship between preprocedural anticoagulation use and clinical and angiographic outcomes. read more here.
Keywords: anticoagulation; myocardial infarction; elevation myocardial; anticoagulation patients ... See more keywords
Anticoagulation in Patients With COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2021.12.023
Abstract: Clinical, laboratory, and autopsy findings support an association between coronavirus disease-2019 (COVID-19) and thromboembolic disease. Acute COVID-19 infection is characterized by mononuclear cell reactivity and pan-endothelialitis, contributing to a high incidence of thrombosis in large… read more here.
Keywords: freedom covid; anticoagulation; anticoagulation patients; covid anticoagulation ... See more keywords
Anticoagulation in patients with cirrhosis and portal vein thrombosis: Safety and beneficial effect on OLT‐free survival
Sign Up to like & getrecommendations! Published in 2019 at "Liver International"
DOI: 10.1111/liv.14231
Abstract: We read with interest the letter by Andrea Mancuso on clinical significance of portal vein thrombosis (PVT) in cirrhosis and potential utility of anticoagulation. In our prospective study, thrombocytopenia and previous decompensation of cirrhosis predicted… read more here.
Keywords: portal vein; vein thrombosis; anticoagulation patients;
COVID-19: another reason for anticoagulation in patients with atrial fibrillation
Sign Up to like & getrecommendations! Published in 2022 at "Heart"
DOI: 10.1136/heartjnl-2022-320845
Abstract: Since the outbreak of the pandemic until early 2022, SARSCoV2 infection (COVID19) has affected more than 410 million individuals worldwide, and of those almost 5.9 million people have died. COVID19 mortality is strongly associated with… read more here.
Keywords: another reason; anticoagulation patients; fibrillation; reason anticoagulation ... See more keywords
Abstract 4139226: Anticoagulation For Patients On Hemodialysis And Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4139226
Abstract: Background: Anticoagulation is the standard treatment for the majority of patients with atrial fibrillation (AF) to reduce the risk of stroke. Anticoagulation is also utilized in patients with end-stage renal disease (ESRD) on hemodialysis (HD)… read more here.
Keywords: new onset; anticoagulation; anticoagulation patients; abstract 4139226 ... See more keywords
Anticoagulation in patients with Embolic Stroke of Unknown Source
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Stroke"
DOI: 10.1177/1747493019826363
Abstract: When warfarin was the mainstay of anticoagulation for the prevention of cardioembolic stroke, the paradigm was essentially “we mustn’t anticoagulate anyone unless we prove that the stroke was cardioembolic.” Now that direct-acting oral anticoagulants are… read more here.
Keywords: anticoagulation; stroke unknown; source; anticoagulation patients ... See more keywords
Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices.
Sign Up to like & getrecommendations! Published in 2024 at "Current pharmaceutical design"
DOI: 10.2174/0113816128291822240131063712
Abstract: Atrial high-rate episodes (AHRE) are atrial tachyarrhythmias that are identified by the use of continuous rhythm monitoring devices such as pacemakers, defibrillators, or implantable cardiac monitors. Nevertheless, the therapeutic implications of these rhythm disturbances remain… read more here.
Keywords: rate episodes; anticoagulation; anticoagulation patients; rate ... See more keywords